# Ascendis Pharma A/S (ASND): MoatMap facts

As of 21 Nov 2026. Research data, not investment advice.

As of 21 Nov 2026, the MoatMap Score for Ascendis Pharma A/S (ASND) is 66/100, ranked against 25,000+ stocks in 38 markets (Quality 76, Value 22, Momentum 65, each scored against its sector).

- MoatMap Score: 66/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 76, Value 22, Momentum 65: each a 0-100 percentile within Healthcare.
- Position: #9,039 overall, #906 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 252.73 USD on 20 Nov 2026.
- Insider filings, last 180 days: directors bought USD 777K; directors sold USD 6.2M.

Source: https://moatmap.ai/stock/ASND
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker
